argenx SE (ARGX)
959.73
-21.60
(-2.20%)
USD |
NASDAQ |
Nov 13, 16:00
959.73
0.00 (0.00%)
After-Hours: 19:59
argenx Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2015 | -5.668M |
| December 31, 2014 | -4.977M |
| September 30, 2014 | -2.278M |
| Date | Value |
|---|---|
| June 30, 2014 | -3.714M |
| March 31, 2014 | -2.551M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -55.06M |
| Cellectis SA | -21.79M |
| Halozyme Therapeutics, Inc. | 247.05M |
| DBV Technologies SA | -64.43M |
| Akari Therapeutics Plc | -4.816M |
Net Income (Quarterly) Related Metrics
| Enterprise Value | 60.66B |
| Earnings Yield | 2.73% |
| Operating Earnings Yield | 2.40% |
| Normalized Earnings Yield | 2.734 |